Forest Laboratories (NYSE: FRX) is a pharmaceutical company headquartered in New York City, USA. Its revenues for the year ended 31 March 2007 were US$3.4 billion. The company's research & development spending has grown rapidly in recent years, and as of 2007, approached almost a billion US dollars a year, which put it on the list of the top 100 global corporations in R&D; spending. Forest Laboratories is also known for licensing European pharmac...
more
Forest Laboratories (NYSE: FRX) is a pharmaceutical company headquartered in New York City, USA. Its revenues for the year ended 31 March 2007 were US$3.4 billion. The company's research & development spending has grown rapidly in recent years, and as of 2007, approached almost a billion US dollars a year, which put it on the list of the top 100 global corporations in R&D; spending. Forest Laboratories is also known for licensing European pharmaceuticals for sale in the United States.
Forest Laboratories is listed on the New York Stock Exchange under FRX.
It should not be confused with the Forest Products Laboratory.
Both Lexapro and Namenda are produced in bulk at the Forest plant in Dublin, Ireland, with secondary processing, such as bottling and blister-packing, being carried out in the USA at plants in New York and St. Louis.
Some of the products Forest Laboratories markets with its partners include:
less
